Flamm J
Department of Urology, Wilhelminenspital, Vienna, Austria.
Br J Urol. 1990 Sep;66(3):286-7. doi: 10.1111/j.1464-410x.1990.tb14928.x.
In patients under the age of 40 years with primary superficial bladder cancer the efficacy of adjuvant topical treatment was the same as in elderly patients (recurrences 23%, progression rate 8%). Patients should therefore be treated on the basis of stage and grade of the tumour regardless of their age.